Clinical Trial Update: Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing once-daily or twice-daily ciclesonide to placebo in asthma patients previously treated with an inhaled corticosteroid has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ciclesonide (ciclesonide)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED